Home / business / Gilead Sciences Seeks Marketing Authorisation from India for Potential Covid-19 Drug Remdesivir

Gilead Sciences Seeks Marketing Authorisation from India for Potential Covid-19 Drug Remdesivir

-
This comes in the backdrop of two Indian pharmaceutical companies -- Cipla and Hetero Labs -- applying to the drug regulator seeking permission to manufacture and sell remdesivir in India.

from Top Business News- News18.com
Read The Rest:timesnownews...
Gilead Sciences Seeks Marketing Authorisation from India for Potential Covid-19 Drug Remdesivir Gilead Sciences Seeks Marketing Authorisation from India for Potential Covid-19 Drug Remdesivir Reviewed by Team Exprssnews on May 29, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.